ImClone Systems Inc (formerly IMCL)

[biophud]

Question(s) to board. I came across these Imclone patent appications--all of which are stem cell-related (see link below). As I recall, several years ago I saw a microarray paper from Princeton (sponsored by Imclone) in which they defined a stem cell expression profile.

My questions-->Why hasn't Imclone mentioned/emphasized their stem-cell research. As I recall, the stem-cell work is not mentioned in the annual report at all.
Where are the patents/patent appications on the early stage products (e.g. RON, FGFR, etc.)? In contrast to the stem-cell research, the Imclone annual report does emphasize these early programs.

Any insight on this apparent disconnect will be appreciated.

biophud

http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FP...